Inhibrx Biosciences, Inc. INBX Accrued Manufacturing Costs
Accrued Manufacturing Costs at other companies
Other financials
Where this comes from
Reported directly by Inhibrx Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.
The official record: Inhibrx Biosciences, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Inhibrx Biosciences, Inc.'s accrued manufacturing costs.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Inhibrx Biosciences, Inc.'s accrued manufacturing costs?
- Inhibrx Biosciences, Inc. (INBX) reported accrued manufacturing costs of $2.24M in Q1 2026.
- How has Inhibrx Biosciences, Inc.'s accrued manufacturing costs changed year-over-year?
- Inhibrx Biosciences, Inc.'s accrued manufacturing costs decreased by 17.5% year-over-year, from $2.72M to $2.24M.
- What is the long-term trend for Inhibrx Biosciences, Inc.'s accrued manufacturing costs?
- Over 2 years (2023 to 2025), Inhibrx Biosciences, Inc.'s accrued manufacturing costs has grown at a 7.0% compound annual growth rate (CAGR), from $6.51M to $7.45M.